Skip to main content
. 2022 May 26;128(15):2898–2907. doi: 10.1002/cncr.34331

FIGURE 2.

FIGURE 2

Cross‐tabulation of the European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology risk groups (A) without and (B) with molecular features known and three molecular profiles.